Related Experiment Video
Updated: Apr 30, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
Prerequisites to implementing a pharmacogenomics program in a large health-care system.
K D Levy1, B S Decker2, J S Carpenter3
1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Clinical Pharmacology and Therapeutics
|May 9, 2014
Summary
Implementing pharmacogenomics (PGx) in healthcare requires specific strategies for successful clinical adoption. This study outlines key requirements for enduring PGx integration into large health systems.
Area of Science:
- Biomedical Sciences
- Clinical Pharmacology
- Genetics
Background:
- Pharmacogenomics (PGx) technology is rapidly evolving.
- Clinical implementation of PGx lags behind research advancements.
- Translating PGx research into routine clinical practice presents challenges.
Purpose of the Study:
- To identify essential requirements for successful pharmacogenomics implementation.
- To guide the integration of PGx into large healthcare systems.
- To bridge the gap between PGx research and clinical practice.
Main Methods:
- Review of clinical pharmacogenomics implementation strategies.
- Analysis of key factors for successful healthcare system integration.
- Case study insights from the Indiana Institute of Personalized Medicine (IIPM).
Main Results:
- Successful PGx implementation requires a multi-faceted approach.
- Key requirements include infrastructure, education, and clinical workflow integration.
- Sustained adoption depends on demonstrating clinical utility and value.
Conclusions:
- A strategic framework is crucial for enduring pharmacogenomics integration.
- Addressing implementation barriers is essential for widespread clinical utility.
- The Indiana Institute of Personalized Medicine (IIPM) provides a model for successful PGx translation.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:27Pharmacogenetics of Drug Metabolism: Overview
194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
01:27Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
01:29Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K